Kazia Therapeutics (KZIA) Other Non-Current Assets (2018 - 2025)

Kazia Therapeutics has reported Other Non-Current Assets for 7 years, with the latest figure at $138207.8 in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Assets fell 14.18% year-over-year to $138207.8; the trailing twelve-month figure through Dec 2025 stood at $138207.8 (down 14.18% YoY), and the FY2025 full-year result was $314169.6, down 19.36% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $138207.8, down from $314169.6 in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.3 million in Q2 2021, with the low at $138207.8 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $616051.9 across 4 years, with a median of $423731.2 in 2023.
• Annual changes were most pronounced in 2021 — Other Non-Current Assets surged 276.04% — and 2024, when it tumbled 64.83%.
• Kazia Therapeutics' Other Non-Current Assets stood at $1.1 million in 2021, then tumbled by 56.48% to $457872.2 in 2023, then sank by 64.83% to $161035.5 in 2024, then slipped by 14.18% to $138207.8 in 2025.
• The last three Other Non-Current Assets figures came in at $138207.8 (Q4 2025), $314169.6 (Q2 2025), and $161035.5 (Q4 2024), per Business Quant data.